View in EDS HTML Full Text PDF Full Text

Prospective phase II study of stereotactic body proton therapy for treatment of primary renal cell carcinoma (SPARE): clinical trial protocol.

Saved in:

Bibliographic Details
Title:	Prospective phase II study of stereotactic body proton therapy for treatment of primary renal cell carcinoma (SPARE): clinical trial protocol.
Authors:	Shaaban, Sherif G¹ (AUTHOR) sherifgamal1082@gmail.com, Chen, Hao² (AUTHOR), Singla, Nirmish³ (AUTHOR), Tran, Anh¹ (AUTHOR), Hu, Chen⁴ (AUTHOR), Ke, Suqi⁴ (AUTHOR), Jarrett, Thomas W³ (AUTHOR), Deville, Curtiland¹ (AUTHOR)
Source:	BMC Cancer. 7/1/2025, Vol. 25 Issue 1, p1-10. 10p.
Database:	Academic Search Ultimate
Full text is not displayed to guests. Login for full access.

Description
ISSN:	14712407
DOI:	10.1186/s12885-025-14486-1